2 ) at the indicated times were subjected to immunoblotting using the indicated antibodies.
Supplementary Figure 4 Senescence sensitivity of fibroblasts from progeroid syndrome patients on IR treatment through extension of G2 checkpoint activation
Lysates of HCA2 or fibroblasts from progeroid syndrome patients collected at the indicated times after distinct doses of IR (0, 1, 2, 5, 10 Gy) were subjected to immunoblotting using the indicated antibodies.
Supplementary Figure 5 Senescence sensitivity of fibroblasts from progeroid syndrome patients on UV treatment through extension of G2 checkpoint activation Lysates of HCA2 or fibroblasts from progeroid syndrome patients collected at the indicated times after distinct doses of UV (0, 1, 2, 5, 10 J/m 2 ) were subjected to immunoblotting using the indicated antibodies. 
